ImmuPharma PLC (25I)
Market Closed
29 Jul, 20:00
XMUN 
€
0. 02
0
0%
€
5.87M Market Cap
- P/E Ratio
400% Div Yield
0 Volume
- Eps
€ 0.02
Previous Close Day Range
0.02 0.02
Year Range
0.01 0.07
Want to track 25I and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 40 days
Summary
25I closed yesterday higher at €0.02, an increase of 0% from Monday's close, completing a monthly decrease of -5.77% or €0. Over the past 12 months, 25I stock gained 63.33%.
25I is not paying dividends to its shareholders.
The last earnings report, released on Jun 03, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Sep 08, 2025.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
25I Chart
ImmuPharma PLC Dividends
 25I 14 Dec 2021 | Other | €2.62 Per Share |
ImmuPharma PLC Earnings
| 8 Sep 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
| 3 Jun 2025 Date | | - Cons. EPS | - EPS |
| 10 Sep 2024 Date | | - Cons. EPS | - EPS |
| 9 Sep 2024 Date | | - Cons. EPS | - EPS |
| 4 Sep 2024 Date | | - Cons. EPS | - EPS |
| 25I 14 Dec 2021 | Other | €2.62 Per Share |
| 8 Sep 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
| 3 Jun 2025 Date | | - Cons. EPS | - EPS |
| 10 Sep 2024 Date | | - Cons. EPS | - EPS |
| 9 Sep 2024 Date | | - Cons. EPS | - EPS |
| 4 Sep 2024 Date | | - Cons. EPS | - EPS |
ImmuPharma PLC (25I) FAQ
What is the stock price today?
The current price is €0.02.
On which exchange is it traded?
ImmuPharma PLC is listed on XFRA.
What is its stock symbol?
The ticker symbol is 25I.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 400%.
What is its market cap?
As of today, the market cap is 5.87M.
When is the next earnings date?
The next earnings report will release on Sep 08, 2025.
Has ImmuPharma PLC ever had a stock split?
No, there has never been a stock split.
ImmuPharma PLC Profile
| Biotechnology Industry | Healthcare Sector | Mr. Timothy Paul McCarthy XIV, FCCA, M.B.A., MBA CEO | XMUN Exchange | GB0033711010 ISIN |
| United Kingdom Country | 6 Employees | - Last Dividend | - Last Split | - IPO Date |
ImmuPharma PLC is a pharmaceutical company dedicated to the development of innovative drugs aimed at treating serious medical conditions. The company positions itself within the biotechnology sector, focusing on creating new therapies for areas with significant unmet medical needs. ImmuPharma utilizes a cost-efficient business model by partnering with industry experts for drug development and distribution, allowing them to expedite the pipeline process.
One of the company's most noteworthy projects is its proprietary peptide technology platform, which underpins its flagship product, Lupuzor, a treatment for lupus that has garnered significant attention in the medical community. This potential breakthrough therapy emphasizes ImmuPharma's commitment to addressing autoimmune conditions.
As a publicly traded company, ImmuPharma plays a pivotal role in advancing medical research and development by strategically collaborating with scientific institutions and maintaining a robust portfolio of innovative drugs. Its presence in the market highlights the vital role biotechnology companies play in enhancing global healthcare through scientific advancements and an unyielding commitment to developing life-altering medicines.
Contact Information
Address: One Bartholomew Close
Phone: 44 20 7206 2650
Website: https://www.immupharma.co.uk
2025 © Marketlog. All Rights Reserved.
